ClinicalTrials.gg
Not yet recruitingNCT06915987Updated Apr 15, 2025

Parkinson Disease and Exercise Snacks

An interventional study of Exercise Intervention in Parkinson Disease, sponsored by University of British Columbia. Not yet recruiting at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2025-04-15.

Sponsored by University of British Columbia · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Parkinson Disease by University of British Columbia — 7 open to participants now, 9 under way, none of them phase 3. Parkinson Disease · University of British Columbia.

Planned enrollment
7th of 13
40 · median 40
Started
2025
with 2 others
No phase
10 of 14
5 open now
Registered
13th of 14
by date

Among the 14 studies in Parkinson Disease by University of British Columbia, this one is the 7th largest by planned enrollment of the 13 interventional ones that give a count, is one of 3 that started in 2025, is one of 10 with no phase, and was the 13th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

7 of the 14 studies in Parkinson Disease by University of British Columbia are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 19 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Parkinson Disease by University of British Columbia, or all of them as a file.
02

Study summary

People with Parkinson's Disease (PD) benefit from exercise, but many face barriers like motor disability, fatigue, and lack of time, leading to reduced activity. This study aims to assess the effectiveness of "exercise snacks," short bursts of vigorous activity that can be done anywhere without equipment or a significant time commitment. These exercise snacks help integrate activity into daily life, making it more accessible for people with PD. The secondary goal is to evaluate the feasibility of this approach through this pilot randomized controlled trial (RCT) to inform a larger, future RCT.

Read the detailed description

Exercise has increasingly become a recognized and valuable component of treatment for individuals with Parkinson's Disease (PD). Numerous studies indicate that exercise can improve motor symptoms, enhance mobility, and contribute to overall well-being. However, despite the well-documented benefits, a significant proportion of people with PD remain inactive. Their physical activity levels often decline over time due to a range of disease-related and practical barriers.

Disease-specific challenges may include motor impairments, fatigue, and apathy. Practical obstacles such as limited time, lack of access to appropriate facilities or programs, adverse weather conditions, and financial constraints also hinder participation. These barriers are compounded in rural and remote communities where exercise resources are scarce. Consequently, there is a pressing need for time-efficient, accessible exercise options adaptable to different stages of PD and feasible for those with varying levels of motor impairment.

Our proposal introduces an innovative intervention called "exercise snacks," consisting of brief, vigorous activity bursts that can be performed anywhere without specialized equipment or a significant time commitment. This approach integrates exercise into daily routines, making it a practical and accessible option for people with PD. Short bouts of exercise are more likely to be maintained and are perceived as more manageable than traditional long-duration workouts. Moreover, this intervention aligns with the World Health Organization Guidelines on Physical Activity and Sedentary Behavior and the Canadian 24-Hour Movement Guidelines for Adults, which encourage breaking up sedentary behavior with short activity breaks.

Exercise interventions must be inclusive to benefit a broader range of people with PD. Many existing studies exclude participants with mild cognitive impairment or those who require assistance with walking or daily activities. Our intervention is specifically designed to accommodate a wide range of abilities. With remote delivery through the Seven Movements platform, the intervention can reach participants in rural or remote areas, where access to traditional exercise programs is limited. This is particularly beneficial in the Interior of British Columbia, where a higher proportion of rural residents face significant healthcare disparities.

Evidence from other populations suggests that exercise snacks can significantly improve cardiovascular fitness and overall health outcomes. High-intensity interval training (HIIT) and similar time-efficient exercise programs have demonstrated comparable benefits to longer-duration aerobic training. We theorize that exercise snacks will offer similar advantages for people with PD by enhancing walking performance, reducing fear of falling, and improving quality of life.

This is an unblinded, block-randomized parallel-group clinical trial involving 40 male and female adults with clinically established PD. Participants will be recruited from Kelowna, British Columbia, through the Humphrey's Family Movement Disorder Clinic and local PD patient support groups. The trial aims to be inclusive, ensuring that the interventions are safe and accessible for a diverse participant population.

Participants with a clinical diagnosis of Parkinson Disease will be randomized to Exercise Snack or Active Movement breaks. Specific hypotheses are: 1) participants in the Exercise Snacks and Active Movement Break groups will be highly adherent to the prescribed activity and 2) people with PD randomized to the Exercise Snacks group will experience improvements in walking performance, reduced fear of falling, and enhanced quality of life compared to the Active Movement Breaks group.

Estimates of the effect of either randomized group assignment includes 1) functional mobility measures (Timed Up and Go, walking speed, balance scales) and 2) psychosocial measures (psychological well-being, fear of falling, quality of life). These will be assessed pre- and post- intervention.

Overall objectives to the study include:

  1. to conduct a 12-week pilot randomized controlled trial (RCT) comparing Exercise Snacks to a placebo exercise intervention (Active Movement Breaks) in people with PD
  2. measure changes in patient-reported activity levels, fear of falling, quality of life, and clinical measures of walking performance and balance
  3. evaluate feasibility outcomes to guide scalability for a fully powered RCT
  4. identify barriers and facilitators for exercise snacks in PD patient population using participant-orientated, qualitative study review
  5. determine eligibility, recruitment, adherence, and dropout rates for a study of this design

This comprehensive Snack PD pilot design will provide robust evidence on the feasibility and efficacy of exercise snacks for people with PD, informing future large-scale trials and broader implementation strategies.

03

Conditions studied

  • Parkinson Disease

Browse trials for

Keywords

  • Parkinson Disease
  • Exercise Snacks
  • Exercise Intervention
04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (19 years of age or older) with Clinically Established PD (Postuma et al., 2015).
  • Medically cleared to exercise by their physician.
  • A score of ≤3 on the modified Hoehn \& Yahr scale (i.e. physically independent, may have unilateral or bilateral clinical signs, including mild impairment of postural reflexes).
  • Have access to a computer, tablet, or smartphone with internet connection for intervention delivery and tracking.

Exclusion criteria

Exclusion criteria

  • Comorbid condition with physical disability preventing participation in exercise (i.e., that cannot be accommodated with modifications to the prescribed exercise).
  • A score of >=4 on the modified Hoehn \& Yahr scale (meaning they may be able to stand or walk but are not physically independent; this typically includes a need for gait aids such as a cane or walker)
  • No access to reliable internet connection.
  • Are currently participating in another clinical trial that would interfere with the study procedures described.
  • Have a scheduled event (e.g. medical or surgical procedure, prolonged travel in the next 3-4 months) that would interrupt participation in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Exercise Snack

    Participants to receive higher intensity exercise snack exercises

    Behavioral: Exercise Intervention

  • Placebo comparator
    Active Movement Breaks

    While not a true placebo (i.e., no intervention at all) participants in this arm will receive low intensity / stretching based exercises throughout the study period.

    Behavioral: Exercise Intervention

Interventions

  • BehavioralExercise Intervention

    Exercise snack group will be higher intensity movements designed to elevate heart rate while active movement break will have low intensity / stretching exercises assigned to them.

    Also known as: Movement Breaks

06

What researchers measure

Primary outcomes

  1. Feasibility of Intervention: completion rate

    Feasibility of the study intervention by using quantitative data from activities logged in the Seven Movements platform is a primary outcome. The investigators will evaluate this outcome measure of feasibility by looking at multiple variables indicating completion of target exercise. One of the variables used to assess this primary outcome measure of feasibility is activities completion rate of at least 2 sessions five days per week, or 10 per week long block. Threshold values are High (\>70%), moderate (50-69%), or low (\<50%) adherence. This data will be extracted from the 7 Movements App.

    Time frame: 10 weeks

  2. Feasibility of Intervention: rate of perceived exertion

    Feasibility of the study intervention by using quantitative data from activities logged in the Seven Movements platform is a primary outcome. The investigators will evaluate this outcome measure of feasibility by looking at multiple variables indicating completion of target exercise. One of the variables used to assess this primary outcome measure of feasibility is the intensity of the exercise expecting a rate of perceived exertion (RPE) of \>4/10 on the Borg CR-10 scale for Exercise Snacks. This data will be extracted from the 7 Movements App.

    Time frame: 10 weeks

  3. Feasibility of Intervention: exercise enjoyment scale

    Feasibility of the study intervention by using quantitative data from activities logged in the Seven Movements platform is a primary outcome. The investigators will evaluate this outcome measure of feasibility by looking at multiple variables indicating completion of target exercise. One of the variables used to assess this primary outcome measure of feasibility a summary of the Exercise Enjoyment Scale ratings of exercises to compare the study groups. This quantitative data will be extracted from the 7 Movements App.

    Time frame: 10 weeks

  4. Adherence to the Intervention: completion rate

    Adherence of the study intervention will be evaluated using quantitative data from activities logged in the Seven Movements platform is a primary outcome. The investigators will evaluate this outcome measure of adherence by looking at multiple variables indicating completion of target exercise. One of the variables used to assess this primary outcome measure of adherence is activities completion rate of at least 2 sessions five days per week, or 10 per week long block. Threshold values are High (\>70%), moderate (50-69%), or low (\<50%) adherence. This data will be extracted from the 7 Movements App.

    Time frame: 10 weeks

  5. Adherence to the Intervention: rate of perceived exertion

    Adherence of the study intervention by using quantitative data from activities logged in the Seven Movements platform is a primary outcome. The investigators will evaluate this outcome measure by looking at multiple variables indicating completion of target exercise. One of the variables used to assess this outcome measure of adherence is the intensity of the exercise expecting a rate of perceived exertion (RPE) of \>4/10 on the Borg CR-10 scale for Exercise Snacks. This data will be extracted from the 7 Movements App.

    Time frame: 10 weeks

  6. Adherence to the Intervention: exercise enjoyment scale

    Adherence of the study intervention by using quantitative data from activities logged in the Seven Movements platform is a primary outcome. The investigators will evaluate this outcome measure of by looking at multiple variables indicating completion of target exercise. One of the variables used to assess this primary outcome measure of adherence is a summary of the Exercise Enjoyment Scale ratings of exercises to compare the study groups. This data will be extracted from the 7 Movements App.

    Time frame: 10 weeks

Secondary outcomes

  1. Qualitative Study Review; perceived acceptability of the intervention using a descriptive, open-ended questionnaire.

    A qualitative study review to be done in partnership with participants upon completion. This outcome measure will be evaluated using a Post Intervention Descriptive Questionnaire to be completed by participants. Open-ended questions in this questionnaire will be cover 4 major themes. One of these themes is participants perceived acceptability of the intervention.

    Time frame: 12 weeks

  2. Qualitative Study Review; the identification of barriers or facilitators to the study using a descriptive, open-ended questionnaire.

    A qualitative study review to be done in partnership with participants upon completion. This outcome measure will be evaluated using a Post Intervention Descriptive Questionnaire to be completed by participants. Open-ended questions in this questionnaire will be cover 4 major themes. One of these themes is participants identification of barriers and facilitators to study activity.

    Time frame: 12 weeks

  3. Qualitative Study Review; participant assessment of the 7 Movements App and technology using a descriptive, open-ended questionnaire.

    A qualitative study review to be done in partnership with participants upon completion. This outcome measure will be evaluated using a Post Intervention Descriptive Questionnaire to be completed by participants. Open-ended questions in this questionnaire will be cover 4 major themes. One of these themes is participants opinions of the 7 Movements platform and technology.

    Time frame: 12 weeks

  4. Qualitative Study Review; study safety concerns as expressed by participants using a descriptive, open-ended questionnaire.

    A qualitative study review to be done in partnership with participants upon completion. This outcome measure will be evaluated using a Post Intervention Descriptive Questionnaire to be completed by participants. Open-ended questions in this questionnaire will be cover 4 major themes. One of these themes is adverse events or safety concerns, as expressed by participants.

    Time frame: 12 weeks

  5. Actigraphy: heart rate measures (bpm).

    Actigraphy data (segmented as sedentary time or mild/moderate/vigorous activity) from five day windows pre-study and post-study. Data collected will include heart rate data collected during two 5 day windows within the study period to assess the effect of Exercise Snack and active movement break interventions on heart rate. The Actigraph LEAP measures heart rate (bpm) using a photoplethysmography (PPG) sensor, a common technology for non-invasive heart rate monitoring.

    Time frame: 12 weeks

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Data will be shared with our Collaborators: Dr. Jonathan Little, Health and Exercise Sciences, UBCO, primary research focus is on how the application of different nutrition and exercise strategies impact glucose control, cardiometabolic health, and inflammation. Dr. Little specializes in the use of exercise snacks for health interventions. Dr. Mary Jung - Health and Exercise Science, UBCO, primary research focus is in health promotion and health behavior changes.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: April 1, 2025 until study completion

Access criteria: Only those listed on the approved REB application will have access to IPD.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2025; primary completion for Dec 2025, 7 months later.

Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 7 months is below that.

Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 14, 2025
First posted
Apr 8, 2025
StartEst.
May 15, 2025
Primary completionEst.
Dec 31, 2025
CompletionEst.
Apr 30, 2026
Last update
Apr 15, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06915987
Responsible party
Daryl Wile (Clinical Investigator, UBC Southern Medical Program CCDPM Clinical Associate Professor, UBC Dept. Medicine, Div. Neurology, University of British Columbia) — Principal investigator
First posted
Apr 8, 2025
Start date
May 15, 2025 (estimated)
Primary completion
Dec 31, 2025 (estimated)
Completion
Apr 30, 2026 (estimated)
Last update
Apr 15, 2025

Study contacts

Daryl J Wile, MD
Contact
dwile@mail.ubc.ca
1-250-575-8576
Jill M Williamson, PhD
Contact
jill.williamson@ubc.ca
1-250-503-8951
Daryl J Wile, MD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion